Lonza

NoSpin HepaRGTM (8.0M cells/vial)

Catalog No : NSHPRG

Fully differentiated HepaRGTM cells supplied in a format that does not require centrifugation following thaw. Each ampule contains ≥8.0 million cells.

Product Overview

 

HepaRGTM Cells are fully-functional, adult-phenotype, human hepatic cells. HepaRGTM Cells exhibit many characteristics similar to primary human hepatocytes and can be used for many of the same applications.  The increased metabolic activity of HepaRG Cells compared to HepG2 enables more predictive value of higher throughput liver toxicity assays conducted in early drug discovery.  

The NoSpin HepaRGTM Cells are HepaRGTM Cells that are provided in a convenient, terminally differentiated, cryopreserved format that does not require the user to centrifuge, resuspend, or count the cells after thawing. This eliminates multiple steps that introduce qualitative and quantitative variability and benefits high-volume labs by reducing the time and effort needed to perform an assay.

Each lot has consistent yield, viability, and functionality across multiple applications.

Using HepaRGTM Cells has never been easier!

Note: The NoSpin HepaRGTM Cells are fully differentiated and non-proliferating.  For the proliferating and non-differentiated version of HepaRGTM Cells, please contact Biopredic International directly.

 

 

Request More Info

Benefits

 

  • Hepatoctye-like morphology and function
  • Widely accepted as screening tool for liver toxicity
  • No centrifugation step required for higher throughput
  • Greater metabolic activity than HepG2 cells

 

Applications

 

  • Drug metabolism
  • Infectious disease
  • ADMETox

 

Storage and Content

1 x cryopreserved ampoule NoSpin HepaRGTM containing ≥8 million cells